Sensus Healthcare to Present at the H.C. Wainwright BioConnect Virtual Conference

Company Management Available for 1×1 Meetings Concurrent with the 40th Annual J.P. Morgan Healthcare Conference January 10-14

BOCA RATON, Fla. , Jan. 06, 2022 (GLOBE NEWSWIRE) —

Sensus Healthcare, Inc. (Nasdaq: SRTS

), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that Joe Sardano, chairman and chief executive officer, will present at the H.C. Wainwright BioConnect Virtual Conference being held January 10-13, 2022.  A pre-recorded presentation will be available on demand beginning Monday, January 10 at 7:00 a.m. Eastern time. Interested parties can access the presentation on the investor relations section of the Company’s website and at this


link.

Also, Sensus management is holding virtual 1×1 meetings with members of the investment community concurrent with the 40

th

Annual J.P. Morgan Healthcare Conference January 10-14, 2022.  Please email


[email protected]


to schedule a meeting.


About Sensus Healthcare

Sensus Healthcare, Inc. is a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for both oncological and non-oncological conditions. The Sculptura™ modulated robotic brachytherapy radiation oncology system provides targeted directional anisotropic radiation therapy (ART) and brachytherapy utilizing our proprietary, state-of-the-art 3D Beam Sculpting™ to treat patients undergoing cancer treatment during surgery, or at the tumor site, fast and efficiently. Sensus also offers its proprietary low-energy X-ray technology known as superficial radiation therapy (SRT), which is the culmination of more than a decade of research and development, to treat non-melanoma skin cancers and keloids with its SRT-100™, SRT-100+™ and SRT-100 Vision™ systems. With its portfolio of innovative medical device products, Sensus provides revolutionary treatment options to enhance the quality of life of patients around the world.

For more information, visit


www.sensushealthcare.com


.


Contact:




LHA Investor Relations

Kim Sutton Golodetz

212-838-3777



[email protected]

#   #   #


Primary Logo